BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8856646)

  • 1. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
    Gallagher JC
    J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin D and osteoporosis].
    Hoszowski K
    Pol Tyg Lek; 1995 Nov; 50(44-47):53-5. PubMed ID: 8643430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of vitamin D and its metabolites in the pathogenesis and therapy of osteoporosis].
    Scharla SH; Ziegler R
    Dtsch Med Wochenschr; 1994 Jun; 119(23):847-51. PubMed ID: 8005057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
    Dechant KL; Goa KL
    Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis prevention and treatment.
    Sambrook PN; Eisman JA
    Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of osteoporosis and fractures.
    Ullom-Minnich P
    Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and bone health in postmenopausal women.
    Malabanan AO; Holick MF
    J Womens Health (Larchmt); 2003 Mar; 12(2):151-6. PubMed ID: 12737713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment of osteoporosis (in the woman)].
    Ziegler R
    Ther Umsch; 1998 Nov; 55(11):696-701. PubMed ID: 9865146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
    Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis of the lumbar spine].
    Villiger PM; Krapf R
    Praxis (Bern 1994); 1996 Oct; 85(43):1354-9. PubMed ID: 8966437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis].
    Rossini M; Viapiana O; Idolazzi L; Fracassi E; Gatti D; Adami S
    Minerva Med; 2007 Feb; 98(1):53-68. PubMed ID: 17372582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis].
    Scharla SH
    MMW Fortschr Med; 1999 Aug; 141(31-32):32-6. PubMed ID: 10726119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.